Hiroki Adachi

1.8k total citations · 1 hit paper
74 papers, 1.1k citations indexed

About

Hiroki Adachi is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Hiroki Adachi has authored 74 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Endocrinology, Diabetes and Metabolism, 25 papers in Molecular Biology and 21 papers in Surgery. Recurrent topics in Hiroki Adachi's work include Diabetes Treatment and Management (20 papers), Metabolism, Diabetes, and Cancer (18 papers) and Renal Diseases and Glomerulopathies (9 papers). Hiroki Adachi is often cited by papers focused on Diabetes Treatment and Management (20 papers), Metabolism, Diabetes, and Cancer (18 papers) and Renal Diseases and Glomerulopathies (9 papers). Hiroki Adachi collaborates with scholars based in Japan and United States. Hiroki Adachi's co-authors include Hidekatsu Yanai, Hisayuki Katsuyama, Mariko Hakoshima, Akahito Sako, Hidetaka Hamasaki, Hitoshi Yokoyama, Akiko Kawaguchi, Keiji Fujimoto, Hideki Yamaya and Yuki Matsui and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Hiroki Adachi

73 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease

2021 337 citations Hidekatsu Yanai, Hiroki Adachi et al. International Journal of Molecular Sciences profile →

Peers

Hiroki Adachi

NEPHR

EDM

EPIDE

SURGE

Ernesto Martín‐Núñez Spain

Belinda Spoto Italy

Mariko Hakoshima Japan

Bancha Satirapoj Thailand

George Marek United States

Yu Ah Hong South Korea

Christiane Rüster Germany

Atsuko Kamijo‐Ikemori Japan

Motoshi Ouchi Japan

Marcelo Costa Batista Brazil

Ernesto Martín‐Núñez Spain

Hiroki Adachi

548 ×1.3

NEPHR

224 ×0.7

EDM

310 ×1.1

112 ×0.5

EPIDE

180 ×0.9

SURGE

Citations per year, relative to Hiroki Adachi Hiroki Adachi (= 1×) peers Ernesto Martín‐Núñez

Countries citing papers authored by Hiroki Adachi

Since Specialization

Citations

This map shows the geographic impact of Hiroki Adachi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Adachi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Adachi more than expected).

Fields of papers citing papers by Hiroki Adachi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroki Adachi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Adachi. The network helps show where Hiroki Adachi may publish in the future.

Co-authorship network of co-authors of Hiroki Adachi

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Adachi. A scholar is included among the top collaborators of Hiroki Adachi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Adachi. Hiroki Adachi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fujihara, Kazuo, Noriko Isobe, Katsuichi Miyamoto, et al.. (2025). Effectiveness of satralizumab in a real-world clinical setting in Japan: Interleukin-6 receptor inhibition in neuromyelitis optica spectrum disorder: A six-month interim analysis of a multicenter medical chart review. Multiple Sclerosis and Related Disorders. 98. 106384–106384. 2 indexed citations

Hirashima, Hideaki, Mitsuhiro Nakamura, Hiroki Adachi, et al.. (2025). Integration test of biaxially rotational dynamic-radiation therapy for nasopharyngeal carcinoma: Efficacy evaluation and dosimetric analysis. Radiotherapy and Oncology. 207. 110879–110879. 1 indexed citations

Yanai, Hidekatsu, Hiroki Adachi, Mariko Hakoshima, & Hisayuki Katsuyama. (2024). Pathology and Treatments of Alzheimer’s Disease Based on Considering Changes in Brain Energy Metabolism Due to Type 2 Diabetes. Molecules. 29(24). 5936–5936. 3 indexed citations

Katsuyama, Hisayuki, et al.. (2024). Retrospective Longitudinal Observational Study on the Long-Term Effects of Sodium-Glucose Cotransporter-2 Inhibitors on the Development of Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetic Japanese Patients. Journal of Clinical Medicine. 13(16). 4929–4929. 1 indexed citations

Yanai, Hidekatsu, et al.. (2024). A Possible Therapeutic Application of the Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease. Cells. 13(5). 450–450. 13 indexed citations

Katsuyama, Hisayuki, et al.. (2024). Real-world effectiveness of imeglimin in patients with type 2 diabetes: A retrospective longitudinal study in Japan. Diabetes Research and Clinical Practice. 213. 111752–111752. 4 indexed citations

Hakoshima, Mariko, et al.. (2023). Clinical, Hematological, Biochemical and Radiological Characteristics for Patients With Splenic Infarction: Case Series With Literature Review. Journal of Clinical Medicine Research. 15(1). 38–50. 6 indexed citations

Yanai, Hidekatsu, Hiroki Adachi, Mariko Hakoshima, & Hisayuki Katsuyama. (2023). Postprandial Hyperlipidemia: Its Pathophysiology, Diagnosis, Atherogenesis, and Treatments. International Journal of Molecular Sciences. 24(18). 13942–13942. 25 indexed citations

Yanai, Hidekatsu, Hiroki Adachi, Mariko Hakoshima, & Hisayuki Katsuyama. (2023). Glucose-Lowering Effects of Imeglimin and Its Possible Beneficial Effects on Diabetic Complications. Biology. 12(5). 726–726. 13 indexed citations

10.

Yanai, Hidekatsu, Hisayuki Katsuyama, Mariko Hakoshima, & Hiroki Adachi. (2023). Urate Transporter 1 Can Be a Therapeutic Target Molecule for Chronic Kidney Disease and Diabetic Kidney Disease: A Retrospective Longitudinal Study. Biomedicines. 11(2). 567–567. 10 indexed citations

11.

Yanai, Hidekatsu, Hiroki Adachi, Mariko Hakoshima, & Hisayuki Katsuyama. (2023). A Possible Exquisite Crosstalk of Urate Transporter 1 With Other Urate Transporters for Chronic Kidney Disease and Cardiovascular Disease Induced by Dotinurad. Cardiology Research. 14(2). 158–160.

12.

Katsuyama, Hisayuki, et al.. (2020). Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Hepatic Fibrosis in Patients With Type 2 Diabetes: A Chart-Based Analysis. Journal of Endocrinology and Metabolism. 10(1). 1–7. 3 indexed citations

13.

Yanai, Hidekatsu, Hiroki Adachi, Hisayuki Katsuyama, et al.. (2018). Exercise Therapy for Patients With Type 2 Diabetes: A Narrative Review. Journal of Clinical Medicine Research. 10(5). 365–369. 30 indexed citations

14.

Yanai, Hidekatsu, Mariko Hakoshima, & Hiroki Adachi. (2018). Which Factor Determines the Duration Required for Relief of Glucotoxicity by the Intensive Insulin Therapy?. Journal of Clinical Medicine Research. 10(7). 606–608. 2 indexed citations

15.

Matsui, Yuki, Keiji Fujimoto, Hiroki Adachi, et al.. (2017). Glomerular mannose-binding lectin deposition in intrinsic antigen-related membranous nephropathy. Nephrology Dialysis Transplantation. 33(5). 832–840. 53 indexed citations

16.

Yanai, Hidekatsu, Mariko Hakoshima, Hiroki Adachi, et al.. (2017). Effects of Six Kinds of Sodium-Glucose Cotransporter 2 Inhibitors on Metabolic Parameters, and Summarized Effect and Its Correlations With Baseline Data. Journal of Clinical Medicine Research. 9(7). 605–612. 24 indexed citations

17.

Matsui, Yuki, et al.. (2017). The long-term outcomes of hepatitis C virus core antigen-positive Japanese renal allograft recipients. Clinical and Experimental Nephrology. 21(6). 1113–1123. 2 indexed citations

18.

Adachi, Hiroki, et al.. (2016). Adiponectin Fractions Influence the Development of Posttransplant Diabetes Mellitus and Cardiovascular Disease in Japanese Renal Transplant Recipients. PLoS ONE. 11(10). e0163899–e0163899. 8 indexed citations

19.

Yanai, Hidekatsu, et al.. (2014). Effects of Intake of Fish or Fish Oils on the Development of Diabetes. Journal of Clinical Medicine Research. 7(1). 8–12. 12 indexed citations

20.

Yanai, Hidekatsu, et al.. (2011). Effects of Liraglutide, a Human Glucagon-Like Peptide-1 Analog, on Glucose/Lipid Metabolism, and Adipocytokines in Patients With Type 2 Diabetes. Journal of Endocrinology and Metabolism. 1(3). 149–151. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact